OIA
Optimum Investment Advisors Portfolio holdings
AUM
$230M
This Quarter Return
+4.92%
1 Year Return
+21.67%
3 Year Return
+92.07%
5 Year Return
+152.73%
10 Year Return
+314.13%
AUM
$244M
AUM Growth
–
Cap. Flow
+$244M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
22.2%
Holding
736
New
736
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$7.6M |
| 2 |
Gilead Sciences
GILD
|
$7.23M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$7.18M |
| 4 |
SPDR S&P 500 ETF Trust
SPY
|
$7.14M |
| 5 |
Apple
AAPL
|
$5.34M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 12.89% |
| 2 | Healthcare | 11.47% |
| 3 | Technology | 10.76% |
| 4 | Industrials | 10.08% |
| 5 | Energy | 7.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Nuveen Municipal Value Fund
NUV
$1.81B
| $918K | 0.38% |
+100,500
| New | +$918K |
|
77
Medallion Financial
MFIN
$242M
| $893K | 0.37% |
+60,000
| New | +$893K |
|
78
Amgen
AMGN
$153B
| $872K | 0.36% |
+7,795
| New | +$872K |
|
79
Pfizer
PFE
$141B
| $865K | 0.35% |
+31,737
| New | +$865K |
|
|
JGT
80
DELISTED
NUVEEN DIVERSIFIED CURRENCY OPPORTUNIES FUND(USA)
JGT
| $821K | 0.34% |
+78,345
| New | +$821K |
|
81
Allstate
ALL
$53.9B
| $813K | 0.33% |
+16,081
| New | +$813K |
|
82
Transocean
RIG
$2.82B
| $809K | 0.33% |
+18,178
| New | +$809K |
|
83
Vanguard Mid-Cap Growth ETF
VOT
$17.5B
| $787K | 0.32% |
+9,233
| New | +$787K |
|
84
Labcorp
LH
$22.8B
| $771K | 0.32% |
+9,050
| New | +$771K |
|
85
Bank of New York Mellon
BK
$73.8B
| $771K | 0.32% |
+25,548
| New | +$771K |
|
86
Amphenol
APH
$135B
| $765K | 0.31% |
+79,072
| New | +$765K |
|
|
BHI
87
DELISTED
Baker Hughes
BHI
| $759K | 0.31% |
+15,460
| New | +$759K |
|
88
Coca-Cola
KO
$297B
| $758K | 0.31% |
+20,023
| New | +$758K |
|
89
DaVita
DVA
$9.72B
| $757K | 0.31% |
+13,310
| New | +$757K |
|
90
WisdomTree Emerging Markets High Dividend Fund
DEM
$3.1B
| $749K | 0.31% |
+14,485
| New | +$749K |
|
91
Halliburton
HAL
$18.4B
| $734K | 0.3% |
+15,240
| New | +$734K |
|
92
H&R Block
HRB
$6.83B
| $733K | 0.3% |
+27,512
| New | +$733K |
|
93
Nucor
NUE
$33.3B
| $728K | 0.3% |
+14,842
| New | +$728K |
|
94
Teva Pharmaceuticals
TEVA
$21.5B
| $712K | 0.29% |
+18,846
| New | +$712K |
|
95
Merck
MRK
$210B
| $711K | 0.29% |
+15,661
| New | +$711K |
|
96
MetLife
MET
$53.6B
| $710K | 0.29% |
+16,968
| New | +$710K |
|
97
Adobe
ADBE
$148B
| $703K | 0.29% |
+13,527
| New | +$703K |
|
98
Old Republic International
ORI
$10B
| $698K | 0.29% |
+45,300
| New | +$698K |
|
99
AT&T
T
$208B
| $697K | 0.29% |
+27,292
| New | +$697K |
|
100
Hasbro
HAS
$11.1B
| $675K | 0.28% |
+14,324
| New | +$675K |
|